- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03878147
Neurodevelopmental Assessment of Children in Uganda and Malawi Using a Software Package
March 13, 2024 updated by: Michael J. Boivin, Michigan State University
Culture-Specific Neurodevelopmental Assessment of HIV-affected Children
The investigators will use Brain Power Games or Village Builder, two different MSU-developed computer-based learning games for children on Tablets, as a neurocognitive "stress test" or medical "challenge" test, in order to evaluate brain/behavior functional integrity in HIV-affected children.
This dual use of BPG is a key innovative feature.
Each of the 5 core BPG games lasts 10 minutes and trains fine motor, monitoring/attention, visual/auditory working memory, spatial navigational learning.
Village Builder (VB) uses similar graphics as BPG, but is a pro-social "world-building" game where children gather and protect resources to build a village.
thus VB emphasizes planning/reasoning (executive function or EF) neurocognitive abilities, while BPG emphasizes attention, memory, and learning tasks.
In As an African child plays with BPG or VB on a touch-screen tablet, we will use games as a dynamic window into the child's developing brain and EF-based frontal lobe development Aim 1. Evaluate concurrent and predictive validity of BPG static (baseline) and dynamic (during 12 training sessions) cognitive assessments Aim 2. Compare the validity of BPG static and dynamic assessments Aim 3. Test the sensitivity of dynamic assessment to learning loss over time by evaluating how much BPG and/or VB performance gains diminish during a 6-month absence of training The investigator's central hypothesis is that the BPG and VB performance gains (dynamic assessment) will explain the additional variation in the gold-standard measures at time points after static (baseline) assessment, and more effectively capture the effects of HIV/ARV exposure and treatment across HIV affected cohorts (HIV, HEU, HUU) of children in Uganda and Malawi.
Study Overview
Status
Active, not recruiting
Intervention / Treatment
Detailed Description
In Phase I of the study we randomize equal numbers of each of three exposure groups of children (perinatally HIV infected, perinatally HIV-exposed but not infected, and unexposed/uninfected children) to one of two intervention arms.
They are randomized to either the Brain Powered Games (BPG) intervention arm of 12 sessions of hour-long training (twice a day for several days weekly at the study clinic), or to the "wait-listed" arm of no BPG training sessions.
In phase II of the protocol (after pretesting, 2 months of waiting followed by post-training testing and then 6-month follow-up testing for both immediate and wait-listed BPG training arms - the wait-listed children will all undergo 12 sessions of village Builder which is a pro-social reasoning/planning strategy game newly developed by our Games for Entertainment and Learning (GEL) lab at Michigan State University (MSU).
In Phase II for the Village Builder children, all children will also undergo neuropsychological testing before and after the 12 training sessions, as well as neuropsychological assessment at six-month follow-up post training.
Study Type
Interventional
Enrollment (Actual)
600
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Michael Boivin, PhD
- Phone Number: (517) 884-0281
- Email: boivin@msu.edu
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
5 years to 12 years (Child)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- HEU and HUU children at least 5 yrs of age and older from the PROMISE ND study (Uganda and Malawi)
- HIV+ children from P1104s (Uganda and Malawi)
- HUU children age-matched from PROMISE ND and P1104s study cohorts (Uganda and Malawi)
Exclusion Criteria:
- Medical history of serious birth complications
- Severe malnutrition
- Bacterial meningitis
- Encephalitis
- Cerebral malaria
- Other known brain injury or disorder requiring hospitalization
- Seizures or other neurological disabilities
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: HIV infected
HIV infected children
|
Brain Powered Games (BPG) uses games for neurocognitive assessment and training, using images and sounds more familiar to African children.
As a computerized cognitive rehabilitation training (CCRT) program designed for Sub-Saharan African school-age children, it can help children infected affected directly or indirectly by HIV.
BPG consists of 5 core games evaluating different cognitive abilities (learning, memory, language, attention).
Each game includes a visual tutorial, several adjustable settings on the administrative side (Admin), and records game play data for research purposes.
Village Builder (VB) is a pro-social reasoning/planning world building strategy type game intended to evaluate frontal lobe executive functions in a culture-friendly and enjoyable game manner.
It consists of many of the village artistic components as used in BPG but orchestrated into a village setting where children must gather resources and protect them in order to expand the capacity of the village.
Other Names:
|
Other: HIV exposed uninfected
HIV exposed, uninfected children
|
Brain Powered Games (BPG) uses games for neurocognitive assessment and training, using images and sounds more familiar to African children.
As a computerized cognitive rehabilitation training (CCRT) program designed for Sub-Saharan African school-age children, it can help children infected affected directly or indirectly by HIV.
BPG consists of 5 core games evaluating different cognitive abilities (learning, memory, language, attention).
Each game includes a visual tutorial, several adjustable settings on the administrative side (Admin), and records game play data for research purposes.
Village Builder (VB) is a pro-social reasoning/planning world building strategy type game intended to evaluate frontal lobe executive functions in a culture-friendly and enjoyable game manner.
It consists of many of the village artistic components as used in BPG but orchestrated into a village setting where children must gather resources and protect them in order to expand the capacity of the village.
Other Names:
|
Active Comparator: HIV unexposed uninfected
HIV unexposed uninfected children (community controls)
|
Brain Powered Games (BPG) uses games for neurocognitive assessment and training, using images and sounds more familiar to African children.
As a computerized cognitive rehabilitation training (CCRT) program designed for Sub-Saharan African school-age children, it can help children infected affected directly or indirectly by HIV.
BPG consists of 5 core games evaluating different cognitive abilities (learning, memory, language, attention).
Each game includes a visual tutorial, several adjustable settings on the administrative side (Admin), and records game play data for research purposes.
Village Builder (VB) is a pro-social reasoning/planning world building strategy type game intended to evaluate frontal lobe executive functions in a culture-friendly and enjoyable game manner.
It consists of many of the village artistic components as used in BPG but orchestrated into a village setting where children must gather resources and protect them in order to expand the capacity of the village.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Kaufman Assessment Battery for Children 2nd Ed (KABC-II) scores
Time Frame: Baseline, 3 months, and 6 months follow-up
|
the KABC-II will be the principal test for cognitive ability.47
It is validated in sub-Saharan Africa48-51 and has been adapted for pediatric HIV research.1,18,46,52-55
Using the Luria model for neuropsychological assessment within KABC-II, the primary outcome variables are the global scores of Sequential Processing (memory), Simultaneous Processing (visual-spatial processing and problem solving), Learning (immediate and delayed memory), Planning (executive reasoning), Delayed Recall, Nonverbal Index (NVI) subtests not dependent on understanding instructions in English, and Mental Processing Index (MPI), a composite of all the cognitive performance areas.
|
Baseline, 3 months, and 6 months follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Test of Variables of Attention (TOVA) scores
Time Frame: Baseline, 3 months, and 6 months follow-up
|
TOVA is a computerized visual continuous performance test used in to screen, diagnose and monitor children and adults at risk for ADHD.56 TOVA consists of the rapid (tachistoscopic) presentation of a large geometric square on the computer screen with a smaller dark box either in the upper position (signal) or lower position (non-signal).
The child is asked to press a switch held in the preferred hand as fast as possible in response to the signal (measuring vigilance attention), but to withhold responding to the non-signal (measuring impulsivity).
|
Baseline, 3 months, and 6 months follow-up
|
Change in CogState scores
Time Frame: Baseline, 3 months, and 6 months follow-up
|
CogState presents a 30-min session that includes playing cards in a game-like manner to assess memory, attention, discrimination learning, and executive function that is non-language dependent.
CogState tests include Card Detection (simple reaction time), Identification (choice reaction time), One-Back Working Memory, and One-Card Learning.
CogState also includes the Groton Maze Task, which can measure visual-motor tracking (Maze Chase) and executive functioning/planning (Maze Learning).
|
Baseline, 3 months, and 6 months follow-up
|
Change in Achenbach Child Behavior Checklist (CBCL) scores
Time Frame: Baseline, 3 months, and 6 months follow-up
|
Parent-based screening tool for emotional and behavioral problems observed in the child.
CBCL is important to assess when a child's social environment is enriched by adult oversight in game assessment and training, reflecting a collateral training benefit
|
Baseline, 3 months, and 6 months follow-up
|
Change in Caldwell Home Observation for the Measurement of the Environment (HOME) scores
Time Frame: Baseline, 3 months, and 6 months follow-up
|
We will use the middle childhood version of the Caldwell Home Observation for the Measurement of the Environment (HOME) validated for use as an important distal measure predictive of our gold standard assessments.The HOME assesses the stimulation and learning opportunities offered by the child's home environment.
|
Baseline, 3 months, and 6 months follow-up
|
Change inCD4+ T-cell counts (HIV cohort only)
Time Frame: Baseline, 3 months, and 6 months follow-up
|
As part of their standard of care (HIV cohort only), CD4 measures will be available from a blood draw taken within a week from the time of neuropsychological assessment as a more proximal predictor of disease effects on assessment performance
|
Baseline, 3 months, and 6 months follow-up
|
Change in viral load (HIV cohort only)
Time Frame: Baseline, 3 months, and 6 months follow-up
|
As part of their standard of care (HIV cohort only), viral load will be available from a blood draw taken within a week from the time of neuropsychological assessment as a more proximal predictor of disease effects on assessment performance
|
Baseline, 3 months, and 6 months follow-up
|
Change in CD8 cell count (HIV cohort only)
Time Frame: Baseline, 3 months, and 6 months follow-up
|
As part of their standard of care (HIV cohort only), CD8 measures will be available from a blood draw taken within a week from the time of neuropsychological assessment as a more proximal predictor of disease effects on assessment performance
|
Baseline, 3 months, and 6 months follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 30, 2020
Primary Completion (Actual)
February 29, 2024
Study Completion (Estimated)
December 23, 2025
Study Registration Dates
First Submitted
March 12, 2019
First Submitted That Met QC Criteria
March 13, 2019
First Posted (Actual)
March 18, 2019
Study Record Updates
Last Update Posted (Actual)
March 15, 2024
Last Update Submitted That Met QC Criteria
March 13, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
- RNA Virus Infections
- Virus Diseases
- Infections
- Blood-Borne Infections
- Communicable Diseases
- Sexually Transmitted Diseases, Viral
- Sexually Transmitted Diseases
- Lentivirus Infections
- Retroviridae Infections
- Immunologic Deficiency Syndromes
- Immune System Diseases
- Urogenital Diseases
- Genital Diseases
- HIV Infections
Other Study ID Numbers
- 2191
- R01HD098027 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
No individual-level data will be made available to other researchers
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV Infections
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
University of California, San DiegoUniversity of California, Los Angeles; University of Southern California; California... and other collaboratorsCompleted
-
Gérond'ifRecruiting
-
University of California, DavisCompleted
-
University of California, San DiegoNational Center for Complementary and Integrative Health (NCCIH)CompletedHIV PositiveUnited States
-
University of ChicagoUniversity of Athens; National Development and Research Institutes, Inc.Completed
-
HIV Prevention Trials NetworkNational Institute on Drug Abuse (NIDA); National Institute of Allergy and...CompletedHIV PositiveIndonesia, Ukraine, Vietnam
-
University of ZimbabweCompleted
-
Florida International UniversityCompleted
-
Boston Children's HospitalNational Institute on Minority Health and Health Disparities (NIMHD)Completed
Clinical Trials on Cognitive Games Training
-
Universidade Federal do Rio de JaneiroUnknown
-
NRG OncologyNational Cancer Institute (NCI)RecruitingBreast Cancer | Cognitive ImpairmentsUnited States
-
University of California, San FranciscoNational Institute of Mental Health (NIMH)CompletedSchizophreniaUnited States
-
University of California, San FranciscoStanley Medical Research InstituteCompletedSchizophreniaUnited States
-
VA Office of Research and DevelopmentCompletedDiabetes Mellitus, Type 2United States
-
Bruyere Research InstituteUniversity of OttawaCompletedMild Cognitive Impairment | Alzheimer's Disease | Mild to Moderate DementiaCanada
-
University of California, San FranciscoNational Institute of Mental Health (NIMH)CompletedSchizophreniaUnited States
-
Icahn School of Medicine at Mount SinaiCompleted
-
Michigan State UniversityUniversity of Michigan; Global Health Uganda LTDCompleted
-
Rush University Medical CenterHarvard Medical School (HMS and HSDM); National Institute of Mental Health... and other collaboratorsCompletedClinical High Risk for PsychosisUnited States